Listed

Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2009

Filed with the SEC on Feb 24, 2010 and accepted by EDGAR at Feb 24, 2010, 16:09 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2009-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2009-01-01 to 2009-12-31$7.42bnus-gaap:CostOfRevenue
Gross profit12 months2009-01-01 to 2009-12-31$3.83bnus-gaap:GrossProfit
Research and development12 months2009-01-01 to 2009-12-31$93.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2009-01-01 to 2009-12-31$1.98bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2009-01-01 to 2009-12-31$1.76bnus-gaap:OperatingIncomeLoss
Interest expense12 months2009-01-01 to 2009-12-31$321.4mus-gaap:InterestExpense
Income tax12 months2009-01-01 to 2009-12-31$490.4mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2009-01-01 to 2009-12-31$891.1mus-gaap:NetIncomeLoss
Diluted EPS12 months2009-01-01 to 2009-12-31$2.99us-gaap:EarningsPerShareDiluted
Basic EPS12 months2009-01-01 to 2009-12-31$2.99us-gaap:EarningsPerShareBasic
Operating cash flow12 months2009-01-01 to 2009-12-31$1.34bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2009-01-01 to 2009-12-31$573.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2009-01-01 to 2009-12-31$231.9mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2009-12-31$301.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2009-12-31$4.73bnus-gaap:AssetsCurrent
Total assetsAt period end2009-12-31$15.82bnus-gaap:Assets
Current liabilitiesAt period end2009-12-31$2.61bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2009-12-31$8.79bnus-gaap:Liabilities
Short-term borrowingsAt period end2009-12-31$316.3mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2009-12-31$6.82bnus-gaap:StockholdersEquity
Shares outstandingAt period end2009-12-31295,746,635 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000950123-10-016350. Last ingested by Listed: Nov 14, 2026, 17:40 ET. Listed shows no prices and gives no investment advice.